You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Novel Insulators in Silicon-on-Insulator Substrates to Improve Nuclear Physics Sensors and Circuits
SBC: CAPORUS TECHNOLOGIES INC Topic: C5333cC53-33c-271423Active pixel sensors have been developed and implemented in a wide array of applications, including image sensors for cameras, sensors for medical imaging, and as detectors for nuclear physics investigations with the Relativistic Heavy Ion Collider and the Large Hadron Collider. Many of these applications, including nuclear physics detectors, medical imaging sensors, and sensors for ...
SBIR Phase II 2023 Department of Energy -
SBIR Phase II:Development of a Distributed Ledger System to Track Environmental Sustainability
SBC: MAP-COLLECTIVE, INC. Topic: ETThe broader/commercial impact of this Small Business Innovation Research (SBIR) Phase II project centers around its potential contribution to the coordination of climate change mitigation performance of governments, industry, and individuals towards a carbon negative future. The automated system for carbon tracking and visualization that this project is evolving could allow it to network many orga ...
SBIR Phase II 2023 National Science Foundation -
SBIR Phase II:Use of ultraviolet light as a treatment for pathogens in strawberry fields
SBC: TRIC ROBOTICS INC. Topic: RThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project seeks to accelerate the transition from chemical pesticides to non-chemical alternatives by providing farmers with a sustainable, long-term solution for managing pests, while reducing agricultural impacts on human health and the environment. Today, strawberry farmers are reliant on chemical p ...
SBIR Phase II 2023 National Science Foundation -
SBIR Phase II: A Blockchain Ecosystem for Encrypting Real World Data and Developing Artificial Intelligence to Optimize Pharmacy Prior Authorization
SBC: Red Oak Strategic, LLC Topic: DLThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to significantly reduce administrative inefficiency in pharmaceutical benefit management processing. The specific focus is on prior authorization processing, where payers and prescribers must reach a consensus on medical necessity. The project delivers a solution to optimize prescription a ...
SBIR Phase II 2023 National Science Foundation -
SBIR Phase II: Building Mathematical Thinking and Problem-solving Skills Together Through Play
SBC: MATHBRIX LLC Topic: LCThis SBIR Phase I project will develop a machine learning-assisted family math preparation program that will help and encourage parents to provide early math instruction to young children, ages 4-8. Along with reading, developing mathematical proficiency is arguably one of the most important skills for young children to acquire, particularly with the growing importance of STEM (science, technology ...
SBIR Phase II 2023 National Science Foundation -
SBIR Phase II:HealthText: Providing digital healthcare navigation for underserved communities in the US
SBC: LISA FITZPATRICK & ASSOCIATES MD PC Topic: DHThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project aims to further develop HealthText, an artificial intelligence (AI) driven digital health information and navigation platform tailored to support the Medicaid population. The project's broader impact lies in its potential to address health disparities in under-resourced communities by providi ...
SBIR Phase II 2023 National Science Foundation -
Increasing Biomass Of TKS/Kazhak Rubber Dandelion To Increase Yields And Reduce Cost Of TKS Rubber
SBC: KULTEVAT, Inc Topic: 82Kultevat Inc. aims to produce natural rubber from Taraxacum kok-saghyz (TKS) at scale toachieve high quality product at a price point that is attractive to customers in particular to US basedcompanies. To date the economics of growing TKS and extracting rubber from its roots at a pricepoint that is competitive with Hevea rubber has not been demonstrated. During Phase I research anRNAi gene silenci ...
SBIR Phase II 2023 Department of Agriculture -
Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension
SBC: INOVODEL, INC. Topic: NHLBISUMMARY Patients with pulmonary hypertension (PH) experience low oxygen saturation, shortness of breath, low quality of life, and a short life span (lt10 years) following diagnosis. These patients frequently present to emergency rooms, and many are admitted to intensive care units (ICUs), straining the health care system. Despite therapy with phosphodiesterase-5 inhibitors, prostacyclin analogs, a ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Developing a clinical diagnostic tool for age-related cochlear synaptopathy.
SBC: GATEWAY BIOTECHNOLOGY, INC. Topic: NIAAge-related hearing loss (ARHL) is the predominant neurodegenerative disease of aging. Recent animal studies have demonstrated that the earliest cochlear pathology due to noise and aging involves a loss of the inner hair cell ribbon synapse. The early consequences of this synaptic loss are not believed to affect hearing sensitivity, but rather, impair speech understanding in background noise. Whil ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health -
Development and Commercialization of a New Molecularly Targeted Imaging Agent for Multiple Myeloma
SBC: Sarya, LLC Topic: 102PROJECT SUMMARY Sarya LLC (Sarya) is a nuclear medicine technology company formed to commercialize radiopharmaceuticals. The goal of this Fast-Track STTR is to develop a new specific imaging agent for diagnosis, staging, and treatment of the hematological cancer, multiple myeloma (MM). MM is the 2nd most common blood cancer with an estimated 32,000 new cases and 13,000 deaths per year. Accurate de ...
STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health